Hôpital Notre-Dame is a hospital in Montreal, Quebec, Canada. It is located on Sherbrooke Street East in the borough of Ville-Marie, across from La Fontaine Park. It was established in 1880, and has been at its present site since 1924.

During the past decade, CHUM - Hopital Notre-Dame conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 102 clinical trials were completed, i.e. on average, 196.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 47 clinical trials were completed. i.e. 671.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHUM - Hopital Notre-Dame" #1 sponsor was "NCIC Clinical Trials Group" with 28 trials, followed by "Radiation Therapy Oncology Group" with 21 trials sponsored, "Centre hospitalier de l'Université de Montréal (CHUM)" with 18 trials sponsored, "National Cancer Institute (NCI)" with 18 trials sponsored and "Canadian Cancer Trials Group" with 18 trials sponsored. Other sponsors include 160 different institutions and companies that sponsored additional 107 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHUM - Hopital Notre-Dame" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator and "Cancer and Leukemia Group B" with 12 trials as a collaborator. Other collaborators include 176 different institutions and companies that were collaborators in the rest 115 trials.

According to Clinical.Site data, the most researched conditions in "CHUM - Hopital Notre-Dame" are "Prostate Cancer" (24 trials), "Breast Cancer" (21 trials), "Lung Cancer" (11 trials), "Colorectal Cancer" (7 trials) and "Ovarian Cancer" (7 trials). Many other conditions were trialed in "CHUM - Hopital Notre-Dame" in a lesser frequency.

Most popular intervention types in "CHUM - Hopital Notre-Dame" are "Drug" (192 trials), "Radiation" (57 trials), "Other" (41 trials), "Biological" (28 trials) and "Procedure" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Laboratory Biomarker Analysis" (13 trials), "Paclitaxel" (13 trials), "Carboplatin" (12 trials) and "Quality-of-Life Assessment" (12 trials). Other intervention names were less common.

The vast majority of trials in "CHUM - Hopital Notre-Dame" are 182 trials for "All" genders, 51 trials for "Female" genders and 28 trials for "Male" genders.

Currently, there are NaN active trials in "CHUM - Hopital Notre-Dame". 1 are not yet recruiting, 10 are recruiting, 45 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 172 completed trials in CHUM - Hopital Notre-Dame, 1 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in CHUM - Hopital Notre-Dame, 11 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 138 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 28 trials that are defined as “Not Applicable".